A psychedelic drug development company designing altered states of consciousness
for mental health therapeutics


Altered States

The acute subjective experience of an altered conscious state is central to treatment outcomes.

Solving the central problem in psychedelic drug development

There is no translational model to distinguish among different altered states of consciousness.

Designing states of consciousness

We’re mapping the biological basis of the varieties of psychedelic experience to enable precision design of modified conscious states.




Osmanthus is a target discovery and phenotypic screening platform for altered conscious states.

We’ve combined natural history, natural language processing, and biochemical data to build a predictive model for the precision design of modified conscious states.


Primers & Probes

Our pipeline is based on a combination approach that uses psychedelic “primer” compounds together with non-psychedelic “probe” compounds that modulate the altered state of consciousness produced by the primer.

Osmanthus in Action

With the Osmanthus screening platform, we’ve identified six probe candidates to date; each with potentially unique therapeutic utility when combined with the lead primer. Future programs in development include a variety of additional primers and probes.

Our Team

Our Advisors

In The News

Business Insider Headline About Mindstate Raising MoneyBusiness Insider headline about Mindstate Raising Money

Inspired to make an impact?

We're always on the lookout for exceptional talent. Submit an application below, and we'll reach out when an opportunity aligns with your skills and aspirations.

Apply Now
Mindstate Design Labs Logo
611 Gateway Blvd
Suite 120
South San Francisco, California, 94080
© 2023 Mindstate Design Labs. All right reserved.